STOCK TITAN
  1. Home
  2. Sec-filings
  3. PACS
  4. [Form 4] PACS Group, Inc. Insider Trading Activity

PACS Group (NASDAQ: PACS) CEO sells shares in 3-day preset plan

Filing Impact
(Very High)
Filing Sentiment
(Very Negative)
Form Type
4

Rhea-AI Filing Summary

PACS Group, Inc. (PACS) reported insider sales by Co-Founder, CEO & Chairman Murray Jason Hulse. Over August 17–19, 2026, he sold a total of 236,116 shares of common stock in open-market transactions under a Rule 10b5-1 trading plan adopted on May 18, 2026. Reported weighted-average prices ranged from about $42.81 to $44.86 per share, with detailed price breakdowns available on request to the company or the SEC staff.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Insider Murray Jason Hulse
Role Co-Founder, CEO & Chairman
Sold 236,116 shs ($10.44M)
Type Security Shares Price Value
Sale Common Stock F1, F5 84,650 $44.2645 $3.75M
Sale Common Stock F1, F6 67 $44.8472 $3K
Sale Common Stock F1, F4 66,797 $44.1807 $2.95M
Sale Common Stock F1, F2 9,758 $43.3416 $423K
Sale Common Stock F1, F3 74,844 $44.2704 $3.31M
Holdings After Transaction: Common Stock — 54,845,416 shares (Direct)
Footnotes (6)
  1. F1. The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026.
  2. F2. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $42.805 to $43.8025 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. F3. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $43.81 to $44.51 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. F4. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $43.81 to $44.67 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  5. F5. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $43.84 to $44.80 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  6. F6. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $44.845 to $44.86 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Total shares sold 236,116 shares Aggregate insider sales of PACS common stock by Murray Jason Hulse over August 17–19, 2026
Shares sold on 2026-08-17 (lot 1) 9,758 shares Open-market sale on August 17, 2026 at $43.3416 weighted-average price
Shares sold on 2026-08-17 (lot 2) 74,844 shares Open-market sale on August 17, 2026 at $44.2704 weighted-average price
Shares sold on 2026-08-18 66,797 shares Open-market sale on August 18, 2026 at $44.1807 weighted-average price
Shares sold on 2026-08-19 (lot 1) 84,650 shares Open-market sale on August 19, 2026 at $44.2645 weighted-average price
Shares sold on 2026-08-19 (lot 2) 67 shares Open-market sale on August 19, 2026 at $44.8472 weighted-average price
Price range 2026-08-17 (lot 1) $42.805 to $43.8025 per share Range of individual sale prices underlying the $43.3416 weighted-average price
Price range 2026-08-19 (lot 2) $44.845 to $44.86 per share Range of individual sale prices underlying the $44.8472 weighted-average price
Rule 10b5-1 trading plan regulatory
"The sale reported ... was effected pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
multiple transactions financial
"The securities were sold in multiple transactions at prices ranging from..."

FAQ

What insider transactions did PACS (PACS) disclose for Murray Jason Hulse?
PACS disclosed that Murray Jason Hulse sold 236,116 shares of common stock on August 17–19, 2026. The sales were executed in multiple open-market transactions at weighted-average prices in the low-to-mid $40s per share.

Were the recent PACS (PACS) insider sales made under a Rule 10b5-1 plan?
Yes. The filing states the sales were made under a Rule 10b5-1 trading plan adopted on May 18, 2026. Such plans allow pre-arranged trading, which can reduce the significance of trade timing for information-based interpretations.

On what dates did PACS (PACS) report insider share sales in August 2026?
PACS reported insider sales on August 17, 18, and 19, 2026. Across these three days, Murray Jason Hulse executed multiple open-market transactions in PACS common stock at weighted-average prices generally between about $42.81 and $44.86 per share.

What price ranges were involved in the August 17, 2026 PACS (PACS) insider trades?
On August 17, 2026, weighted-average sale prices were based on trades between $42.805 and $43.8025 per share and between $43.81 and $44.51 per share. The filing notes that detailed trade-by-trade pricing data is available upon request.

How many PACS (PACS) shares did the CEO sell on August 18 and 19, 2026?
The CEO sold 66,797 shares on August 18, 2026 and 84,717 shares on August 19, 2026. These transactions occurred at weighted-average prices with underlying individual trades ranging from $43.81 to $44.80 and $44.845 to $44.86 per share, respectively.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Murray Jason Hulse
(Last)(First)(Middle)
C/O PACS GROUP, INC.
90 S. 400 W. SUITE 700
(Street)
SALT LAKE CITY UTAH 84101
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
PACS Group, Inc. [ PACS ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirectorX10% Owner
XOfficer (give title below)Other (specify below)
Co-Founder, CEO & Chairman
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/17/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/17/2026S(1)9,758D$43.3416(2)55,071,774D
Common Stock08/17/2026S(1)74,844D$44.2704(3)54,996,930D
Common Stock08/18/2026S(1)66,797D$44.1807(4)54,930,133D
Common Stock08/19/2026S(1)84,650D$44.2645(5)54,845,483D
Common Stock08/19/2026S(1)67D$44.8472(6)54,845,416D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026.
2. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $42.805 to $43.8025 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $43.81 to $44.51 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
4. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $43.81 to $44.67 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
5. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $43.84 to $44.80 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
6. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $44.845 to $44.86 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Remarks:
/s/ John Mitchell, Attorney-in-Fact08/19/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR